These components include insulin resistance, hyperglycemia with prediabetes or type 2 diabetes mellitus (DM), dyslipidemia, and hypertension, points that constitute a systemic metabolic dysfunction
Irwin adds that the interplay between fat cells and estrogen is a particular concern for estrogen-receptor positive breast cancers like mine (and 70 percent of breast cancer patients in general): Weight loss and metabolic changes associated with GLP-1s may favorably influence breast cancer risk because they likely reduce estrogen levels in postmenopausal women. For his own patients, Dr
A few important notes about titration
Clinical trials have shown that Wegovy induces significantly greater weight loss compared to other anti-obesity medications, with a substantial proportion of patients achieving clinically meaningful weight reduction
Always consult with a qualified healthcare provider for any medical concerns or questions you may have.
Las indicaciones estudiadas o atribuidas (longevidad, retina, cardiovascular, neuroendocrina) deben tratarse como exploratorias y no establecidas clnicamente